ABVC BioPharma, Inc. (ABVC) vs Seres Therapeutics, Inc. (MCRB)
- ABVC BioPharma, Inc. ABVC 0.92 −1.08%
- Seres Therapeutics, Inc. MCRB 2.46 −2.77%
ABVC BioPharma, Inc. and Seres Therapeutics, Inc. are both Biotechnology companies. ABVC BioPharma, Inc. and Seres Therapeutics, Inc. are of similar size ($25.2M and $24.9M). ABVC BioPharma, Inc. grew revenue faster over the last twelve months: 5,035.4% against −98.5%. ABVC BioPharma, Inc. has the higher net margin (0.00% vs −1,192.9%) and the higher return on invested capital (−33.5% vs −277.3%). Across the 17 metrics below, ABVC BioPharma, Inc. leads on 12 and Seres Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | ABVC | MCRB | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.97% | 100.00% | 65.16% |
| Operating margin | 0.00% | (4,462.77%) | 0.00% |
| Net margin | 0.00% | (1,192.94%) | 0.00% |
| Free cash flow margin | 0.00% | (2,721.83%) | 0.00% |
| Return on equity | (65.32%) | (66.57%) | (56.36%) |
| Return on assets | (39.88%) | (18.31%) | (48.04%) |
| Return on invested capital | (33.45%) | (277.30%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack